Jameson, C.
Boulton, K. A.
Silove, N.
Nanan, R.
Guastella, A. J. https://orcid.org/0000-0001-8178-4625
Article History
Received: 4 May 2022
Revised: 16 September 2022
Accepted: 3 October 2022
First Online: 25 October 2022
Competing interests
: Author AG and NS declare fee for service support of pharmaceutical clinical trials for autism spectrum disorder in their clinic services (including a current and past trial with Axial Therapeutics of a gut-based therapy). These authors receive no personal financial gain from this contracted work. Authors CJ, RN, and KB report no competing interests.